​

Translational Development Acquisition (TDAC) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Translational Development Acquisition Revenue Highlights

00

Translational Development Acquisition Revenue by Period

Translational Development Acquisition Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31--

Translational Development Acquisition generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Translational Development Acquisition Revenue by Quarter

DateRevenueChange
2026-03-31--100.00%
2025-12-31$-553.29K-501.87%
2025-09-30$137.68K-28.20%
2025-06-30$191.76K-14.33%
2025-03-31$223.85K100.00%
2024-12-31-100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-05-31--

Translational Development Acquisition generated - in revenue during Q1 2026, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Translational Development Acquisition Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CEPCantor Equity Partners, Inc. Class A Ordinary Shares--
FACTFACT II Acquisition--
MACIMelar Acquisition Corp. I--
TDACTranslational Development Acquisition--
HCMAHCM Acquisition--
SZZLSizzle Acquisition Corp. II--

TDAC Revenue FAQ

What is Translational Development Acquisition’s yearly revenue?

Translational Development Acquisition's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. TDAC's yearly revenue for 2022 was $0, representing an increase of 0% compared to 2021.

What is Translational Development Acquisition’s quarterly revenue?

Translational Development Acquisition's quarterly revenue for Q1 2026 was $0, a -100.00% decrease from the previous quarter (Q4 2025), and a -100.00% decrease year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $-553K, a -501.87% decrease from the previous quarter (Q3 2025), and a 0% increase year-over-year (Q4 2024). TDAC's quarterly revenue for Q3 2025 was $137.68K, a -28.20% decrease from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024).

What is Translational Development Acquisition’s revenue growth rate?

Translational Development Acquisition's revenue growth rate for the last 3 years (2022-2024) was 0%